For the Inventor, By the Inventor

Enter inventor name

Marek Kirszenbaum

USPTO Granted Patents = 6

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 1)

Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 10(Granted Patents)

Location History:

Jouy-en-Josas, FR (1994)
Orsay, FR (1999 - 2001)
Paris, FR (2003 - 2007)
Vanves, FR (2017)

Company Filing History:

Commissariat a L'energie Atomique

Institut National De La Recherche Agronomique (inra)

Institut Pasteur

4. 1 out of 4,872

Commissariat À L'Énergie Atomique Et Aux Énergies Alternatives

where one patent can have more than one assignee

Years Active: 1994-2017

Loading Chart...

Loading Chart...

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9623015 - Combination of an anti-cancer agent such as a tyrosinekinase inhibitor and a STAT5 antagonist, preferably a thiazolidinedione, for eliminating hematologic cancer stem cells in vivo and for preventing hematologic cancer relapse (2017-04-18),

2. 7235632 - Isolated mammalian protein present at the surface of all lymphoid progenitor cells and all mature NK cells and uses thereof (2007-06-26),

3. 6528304 - Eukaryotic cells expressing at their surface at least an HLA-G isoform and their applications (2003-03-04),

4. 6291659 - Transcripts of the MHC class I HLA-G gene and their applications (2001-09-18),

5. 5856442 - Transcripts of the MHC class I HLA-G gene and their applications (1999-01-05),

6. 5328827 - Specific DNA molecular probes for Bos-type male genome (1994-07-12),

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…